ESPR
Esperion Therapeutics, Inc. Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →
Esperion Therapeutics, Inc. (ESPR) closed at $3.40 as of 2026-02-02, trading 10.4% above its 200-week moving average of $3.08. The stock moved further from the line this week, up from 9.7% last week. The 14-week RSI sits at 55, indicating neutral momentum.
Over the past 610 weeks of data, ESPR has crossed below its 200-week moving average 14 times. On average, these episodes lasted 28 weeks. Historically, investors who bought ESPR at the start of these episodes saw an average one-year return of +110.6%.
With a market cap of $813 million, ESPR is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. The stock trades at -1.6x book value.
Share count has increased 221.7% over three years, indicating dilution.
Over the past 11.8 years, a hypothetical investment of $100 in ESPR would have grown to $22, compared to $431 for the S&P 500. ESPR has returned -12.3% annualized vs 13.2% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: ESPR vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ESPR Crosses Below the Line?
Across 13 historical episodes, buying ESPR when it crossed below its 200-week moving average produced an average return of +50.7% after 12 months (median -6.0%), compared to +20.5% for the S&P 500 over the same periods. 46% of those episodes were profitable after one year. After 24 months, the average return was -38.5% vs +35.5% for the index.
Each line shows $100 invested at the moment ESPR crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ESPR has crossed below its 200-week MA 14 times with an average 1-year return of +110.6% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jun 2014 | Jun 2014 | 2 | 2.6% | +589.7% | -77.2% |
| Jul 2014 | Jul 2014 | 2 | 8.6% | +577.0% | -76.7% |
| Sep 2014 | Sep 2014 | 1 | 1.0% | +195.1% | -77.5% |
| Sep 2015 | Feb 2017 | 74 | 67.9% | -48.3% | -87.3% |
| Mar 2017 | Mar 2017 | 1 | 17.9% | +223.3% | -85.6% |
| May 2018 | Jul 2018 | 6 | 6.9% | +39.4% | -90.9% |
| Oct 2018 | Oct 2018 | 1 | 1.4% | -4.6% | -91.9% |
| Dec 2018 | Jan 2019 | 3 | 7.4% | +37.3% | -91.3% |
| Aug 2019 | Oct 2019 | 7 | 6.8% | -12.6% | -90.8% |
| Nov 2019 | Nov 2019 | 1 | 0.3% | -33.2% | -91.0% |
| Mar 2020 | May 2020 | 8 | 26.0% | -11.9% | -90.1% |
| May 2020 | Jun 2020 | 1 | 0.7% | -53.0% | -92.0% |
| Jul 2020 | Nov 2025 | 279 | 95.6% | -61.0% | -91.5% |
| Jan 2026 | Jan 2026 | 1 | 2.1% | N/A | +11.8% |
| Average | 28 | — | +110.6% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02